415 Capital — Full Portfolio

Corflow develops diagnostic and therapeutic solutions to restore healthy microvascular blood flow in the human body, serving the cardiovascular medical device industry.

HardwareHealthtechMedical Devices

Martin(Physician Co-Founder)Rick Geoffrion(Chairman and CEO)

Co-investorsBRBroadview VenturesLALaerdal Million Lives FundPAPanakes PartnersKOKorysMÉMérieux Equity Partners

Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock.

HardwareHealthtechMedical DevicesCampbell, US

NSNitin Salunke(President & CEO)inJean Orth(Executive Officer)MMMariam Maghribi(Executive Officer, Director)

BoardCasey Gordon(Director)Christopher Shen(Director)Bihua Chen(Director)

Co-investorsAMAmed VenturesTHThe Capital PartnershipNONovo HoldingsUNUnorthodox Ventures

Boston Heart Diagnostics provides diagnostic testing and cardiovascular health characterization services for disease prevention and health improvement.

Digital HealthHealthtechMedical DevicesBoston, US

Co-investorsKEKeiretsu ForumSISilversmith Capital Partners

Cardiac Success develops a transcatheter ventricular remodeling device to treat patients with heart failure with reduced ejection fraction (HFrEF) by reshaping the dilated left ventricle.

BiotechHealthtechMedical Devices

Dr. Shimon Eckhouse(Chairman & Co-Founder)David Neustadter, PhD(CTO & Founder)Boaz Manash(CEO)in

PartnerFGFrederik Groenewegen· led

HealthtechSanta Rosa, US

Fred Khosravi(Director)Tony Fields(Executive Officer)

BoardJames Eadie(Director)APAzin Parhizgar(Executive Officer, Director)inHenry A. Plain(Director)Leo Nelson Hopkins(Director)

Co-investorsLILightstone VenturesEAEaston Capital

Distalmotion develops DEXTER, a surgical robotics system for minimally invasive procedures such as hernia repair, cholecystectomy, and hysterectomy, used by surgeons and clinical teams.

HealthtechMedical DevicesRoboticsLausanne, CH

PartnerFGFrederik Groenewegen· led

Co-investors4S4see VenturesPRPrivilège VenturesZÜZühlke Ventures

Endovascular Engineering develops clot removal technologies targeting venous thromboembolism.

Medical Devices

Co-investorsNONorwest Venture PartnersS3S3 Ventures

BiotechHealthtechWayne, US

Robert Giasolli(Executive Officer)Bruce J. Shook(Executive Officer, Director)Carol Burns(Executive Officer)Marc Penna(Executive Officer)Monica Klos(Executive Officer)Michael Longo(Executive Officer)

Co-investorsH.H.I.G. CapitalH.H.I.G. HealthBridge PartnersRURunway Growth CapitalH.H.I.G. BioHealth PartnersNENew Enterprise Associates (NEA)VEVensana Capital

Laza Medical develops an AI- and robotics-powered ultrasound imaging system for structural heart, electrophysiology, and diagnostic cardiac procedures, combining real-time 3D heart modeling, procedural guidance, and robotic probe control.

AI & Machine LearningBiotechMedical DevicesRoboticsCampbell, US

Amr Salahieh(Executive Officer, Director, Promoter)PGPablo Garcia Kilroy(General Manager)inCasey Gordon(Director)Mariam Maghribi(Executive Officer)David Voris(Executive Officer)

Co-investorsPAPage One VenturesTHThe Capital PartnershipUNUnorthodox Ventures

HealthtechTewksbury, US

Lisa Mastromattei(Executive Officer)Lisa Wipperman Heine(Executive Officer)Sophia Wong(Executive Officer)Richard P. Geoffrion(Executive Officer, Director)

BoardMartien Van Osch(Director)Daniel Cole(Director)

Co-investorsQIQiming Venture PartnersOXOxford Bioscience Partners

R3 Vascular develops bioresorbable vascular scaffolds made from a proprietary polymer using a proprietary manufacturing process.

BiotechHealthtechMedical DevicesNew MaterialsMountain View, US

Kamal Ramzipoor(CTO, Founder)inChristopher M. Owens(President and Chief Executive Officer)Mahmood Razavi(Director)JeanMarie Markham(Director)

BoardFGFrederik Groenewegen(Director)inJohn Springer(Director)

Recor Medical develops the Paradise Ultrasound Renal Denervation system, a therapy that uses ultrasound technology to lower blood pressure in patients with hypertension.

BiotechHardwareHealthtechMedical DevicesPalo Alto, US

JSJacques Seguin(Director)in

BoardAndrew M. Weiss(Executive Officer, Director)APAntoine Papiernik(Executive Officer, Director)inKazumichi Kobayashi(Director)F. Thomas Watkins(Director)Frank Litvack(Director)

Co-investorsSOSofinnova Partners

TRiCares develops the Topaz Transfemoral Tricuspid Heart Valve Replacement (TTVR) System, a minimally invasive device for treating tricuspid regurgitation.

BiotechHardwareHealthtechMedical DevicesFrance, FR

AEAhmed Elmouelhi(President & CEO)inEsther Gerteis(Senior VP Medical & Regulatory Affairs)inMichael Litzenburger(VP R&D)in

PartnerFGFrederik Groenewegen· led

Co-investorsEUEuropean Investment BankANAndera PartnersBABayern KapitalBIBioMedPartnersKAKarista

Endologix develops endovascular medical devices for treating vascular conditions such as abdominal aortic aneurysms and peripheral arterial disease in the femoropopliteal arteries.

HardwareHealthtechMedical Devices

John Liddicoat(President and Chief Executive Officer)Graham Phillips(Chief Operating Officer)Cindy Pinto(Chief Financial Officer)Jorge O'Hara(Chief Commercial Officer)in

Co-investorsNENew Enterprise Associates (NEA)DEDeerfield Management Company

Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease.

HealthtechMedical DevicesWayne, US

BJBruce J. Shook(President and CEO)MKMonica Klos(Executive Officer)inNeil Hattangadi(Director)inPeter Schneider(Director)Mark Garcia(Director)Dennis W. Wahr(Director)

Co-investorsNENew Enterprise Associates (NEA)GIGilde HealthcareLILightstone VenturesVEVensana Capital